IMRX vs WDAY · $124.2M cap vs P/E 135, rev $5.19B
Immuneering Corp (IMRX) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
IMRX does not have a complete income-statement cache yet.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
IMRX currently screens at market cap $124.2M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the IMRX and WDAY stock pages for the full models.
Not investment advice.